Roflumilast D4
| Product Name | Roflumilast D4 |
|---|---|
| Alternate Names | Roflumilast Stable Isotopes, Stable Isotopes of Roflumilast |
| CAT No. | CS-O-02897 |
| CAS No. | 162401-32-3(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 407.23 g/mol |
| Mol. For. | C₁₇H₁₀D₄Cl₂F₂N₂O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Roflumilast |
| Purity | 98.64 |
| Therapeutic | Anti-Asthma / COPD |
| Smileys | FC(F)OC1=C(C=C(C(NC(C(Cl)=CN=C2)=C2Cl)=O)C=C1)OCC3C([2H])([2H])C3([2H])[2H] |
| Canonical Smiles | C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F |
| InchIKey | MNDBXUUTURYVHR-UHFFFAOYSA-N |
| Inchl | InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24) |
| IUPAC | 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Roflumilast D4 is a deuterated version of the drug Roflumilast, which is a phosphodiesterase 4 (PDE4) inhibitor. This medication is used to treat chronic obstructive pulmonary disease (COPD) in patients with a history of severe exacerbations. COPD is a progressive lung disease characterized by inflammation and narrowing of the airways, leading to breathing difficulties and reduced lung function.
Roflumilast D4 works by reducing inflammation in the lungs, which helps to improve breathing and reduce the risk of exacerbations. It is believed to do this by inhibiting the activity of PDE4, an enzyme that is involved in the production of inflammatory molecules in the body.
Chemically, Roflumilast D4 is a deuterated version of Roflumilast, meaning that it contains deuterium atoms in place of some of the hydrogen atoms in the molecule. Deuterium is a stable isotope of hydrogen that has a slightly greater mass, which can affect the way that the drug is metabolized in the body. This modification can increase the half-life of the drug, which may improve its effectiveness and reduce the frequency of dosing required.
In summary, Roflumilast D4 is a medication used to treat COPD by reducing inflammation in the lungs. It is a deuterated version of Roflumilast, which may improve its pharmacokinetic properties.
Get an Instant Quote
Related Compounds
Roflumilast N-oxide D4 | Roflumilast Dimer-D8 |